Sushil K Srivastava

Title: The Innovative Contributions of Sushil K. Srivastava

Introduction

Sushil K. Srivastava, based in Dayton, NJ, is a notable inventor with a significant portfolio of nine patents. His work primarily focuses on advancements in pharmaceutical compositions, particularly in the realm of HIV treatment. His innovative spirit and dedication to research have made substantial contributions to the medical field.

Latest Patents

Among his latest inventions is a sophisticated process for preparing atazanavir bisulfate, an HIV protease inhibitor. This process involves reacting a solution of atazanavir free base with concentrated sulfuric acid, optimizing the conditions to ensure the formation of Form A crystals of atazanavir bisulfate. Furthermore, his recent patents detail the creation of a novel form of atazanavir bisulfate, known as Form E3, which is characterized as a highly crystalline triethanolate solvate derived from ethanol. This breakthrough indicates a refined approach to enhancing the pharmaceutical efficacy of the compound.

Career Highlights

During his professional journey, Sushil K. Srivastava has made substantial impacts while working with prominent companies such as Bristol-Myers Squibb Company. His contributions to the company have helped advance the development of vital medications and formulate effective treatment options for those living with HIV.

Collaborations

Sushil has collaborated with esteemed professionals in his field, including John J. Venit, contributing to a synergistic approach in research and development efforts. These partnerships have fostered an environment of innovation and have propelled the advancement of pharmaceutical science.

Conclusion

In summary, Sushil K. Srivastava stands out as an impactful inventor whose patents are vital in the fight against HIV. His ongoing efforts and collaborations in pharmaceutical research continue to shape the landscape of medicinal chemistry, marking him as a key player in the field of healthcare innovation.